Stockreport

BTIG Sees Upside in ImmunityBio, Inc. (IBRX), Cites Strong 2026 ANKTIVA Sales Growth [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF BTIG Sees Upside in ImmunityBio, Inc. (IBRX), Cites Strong 2026 ANKTIVA Sales Growth TheFly reported on March 11 that BTIG gave IBRX a Buy rating and assigned a $13 p [Read more]